Tag: tumour

TPCE

Evaluation of transpulmonary chemoembolization (TPCE)

The incidence of lung cancer has increased considerably in the last few decades with the lung as the most common site of metastatic involvement....
hospices

Fifty patients treated with Epione robot at the Hospices Civils de...

The 50th patient has been treated using the Epione robot from Quantum Surgical by the team of Laurent Milot, deputy chief vascular and interventional...

Lyon hospital group adopts Epione robotic ablation platform

Hospices Civils de Lyon (HCL; Lyon, France) has acquired Epione, the robotic platform developed by Quantum Surgical (QS) that is designed to enable minimally...

New liquid embolic multicentre trial successfully enrols final patient

Fluidx Medical announces completion of trial enrolment for its GPX embolic device. In this multicentre trial, GPX was used to treat a variety of...
embolic device

New embolic device demonstrates superior vessel filling in tumour models

Fluidx Medical disclosed study results examining extent of vessel filling using the GPX embolic device compared to microspheres, a common treatment for many types...

Transarterial radioembolization (TARE) with Yttrium-90 in paediatric primary liver tumours

Primary paediatric liver cancer is a rare disease, accounting for 1–2% of childhood cancers, or about 150 new diagnoses of paediatric liver malignancy per...
embolic device

Metastatic tumour treatment with novel GPX embolic device

An embolic device by Fluidx Medical has been used successfully in a variety of complex cancer cases, according to a company press release. As part...
TheraSphere treatment

EPOCH trial reignites radioembolization as treatment for colorectal liver metastases

In the trial, radioembolization (also called selective internal radiation therapy ) using glass beads (Therasphere; Boston Scientific) containing radioactive yttrium (Y-90) was used as...
Bernhard Gebauer

How SIR-Spheres® Y-90 resin microspheres can improve patient outcomes, offer greater...

This advertorial is sponsored by Sirtex Medical. Two  experts in the field of interventional radiology,  Bernhard Gebauer (head of interventional radiology at Charité – Universitätsmedizin...

Cryoablation could freeze out lumpectomy in early-stage, low-risk breast tumours

A pilot study, published in the Journal of Cancer Therapy, reveals that percutaneous cryoablation of early-stage, low-risk breast cancer tumours smaller than 15mm presents a...
lung sarcoma

Percutaneous microwave and cryoablation suitable for sarcoma lung metastases treatment  

Percutaneous microwave and cryoablation allow for repeat minimally invasive treatment of sarcoma lung metastases with mild complications, according to the conclusions of a study...
cancer

Biopsy alternative: ‘Wearable’ device captures cancer cells from blood

A prototype wearable device, tested in animal models, can continuously collect live cancer cells directly from a patient’s blood. Proposed as an alternative to...

Guerbet announces Lausanne partnership to evaluate immunogenic potential of cTACE

Guerbet has announced a partnership with the Department of Radiodiagnosis and Interventional Radiology of Lausanne's University Hospital (CHUV) and the Lausanne Center for Experimental...
Cluster of two well-preserved tumour cells obtained by left hypogastric artery sampling

Selective liquid biopsy yields promising results

Laboratory techniques that make genetic profiling and mutation monitoring of tumours more readily accessible than by direct tissue biopsy have recently been introduced. These...